Order Article Reprints

Wong S, Brown AD, Abrahams AB, Nurzak AN, Eltaher HM, Sykes DA, Veprintsev DB, Fone KCF, Dixon JE, King MV. A Modified Cell-Penetrating Peptide Enhances Insulin and Oxytocin Delivery across an RPMI 2650 Nasal Epithelial Cell Barrier In Vitro. Pharmaceutics. 2024; 16(10):1267. https://doi.org/10.3390/pharmaceutics16101267

Wong, Sara, Alexander D. Brown, Abigail B. Abrahams, An Nisaa Nurzak, Hoda M. Eltaher, David A. Sykes, Dmitry B. Veprintsev, Kevin C. F. Fone, James E. Dixon, and Madeleine V. King. 2024. "A Modified Cell-Penetrating Peptide Enhances Insulin and Oxytocin Delivery across an RPMI 2650 Nasal Epithelial Cell Barrier In Vitro" Pharmaceutics 16, no. 10: 1267. https://doi.org/10.3390/pharmaceutics16101267

Wong, S., Brown, A. D., Abrahams, A. B., Nurzak, A. N., Eltaher, H. M., Sykes, D. A., Veprintsev, D. B., Fone, K. C. F., Dixon, J. E., & King, M. V. (2024). A Modified Cell-Penetrating Peptide Enhances Insulin and Oxytocin Delivery across an RPMI 2650 Nasal Epithelial Cell Barrier In Vitro. Pharmaceutics, 16(10), 1267. https://doi.org/10.3390/pharmaceutics16101267